Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-01 6:30 pm Sale |
2024-03-28 | 13D | Cogent Biosciences, Inc. COGT |
Fairmount Funds Management LLC | 9,986,556 9.900% |
-31,519 (-0.31%) |
Filing History |
| 2024-04-01 5:42 pm Sale |
2024-03-28 | 13D | Apogee Therapeutics, Inc. APGE |
Fairmount Funds Management LLC | 4,762,558 9.990% |
-640,495 (-11.85%) |
Filing History |
| 2024-03-27 4:37 pm Sale |
2024-03-25 | 13D | Cogent Biosciences, Inc. COGT |
Fairmount Funds Management LLC | 10,018,075 9.900% |
-13,061,066 (-56.59%) |
Filing History |
| 2024-02-16 6:55 pm Purchase |
2024-02-16 | 13D | Cogent Biosciences, Inc. COGT |
Fairmount Funds Management LLC | 23,079,141 18.890% |
3,116,577 (+15.61%) |
Filing History |
| 2024-02-14 3:49 pm Sale |
2023-12-31 | 13G | Nuvalent, Inc. NUVL |
Fairmount Funds Management LLC | 1,924,626 3.400% |
-864,355 (-30.99%) |
Filing History |
| 2024-02-14 3:48 pm Sale |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Fairmount Funds Management LLC | 0 0.000% |
-6,018,465 (Position Closed) |
Filing History |
| 2024-02-14 3:48 pm Purchase |
2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 3,633,965 9.900% |
1,732,568 (+91.12%) |
Filing History |
| 2024-02-14 3:47 pm Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Fairmount Funds Management LLC | 6,632,015 9.900% |
1,362,728 (+25.86%) |
Filing History |
| 2024-02-14 3:46 pm Purchase |
2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
Fairmount Funds Management LLC | 2,360,077 4.900% |
15,097 (+0.64%) |
Filing History |
| 2024-02-14 3:46 pm Purchase |
2023-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Fairmount Funds Management LLC | 2,883,221 8.100% |
740,169 (+34.54%) |
Filing History |
| 2024-02-14 3:45 pm Sale |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Fairmount Funds Management LLC | 322,893 0.400% |
-3,358,563 (-91.23%) |
Filing History |
| 2024-02-14 3:45 pm Purchase |
2023-12-31 | 13G | Enliven Therapeutics, Inc. ELVN |
Fairmount Funds Management LLC | 2,131,369 5.200% |
6,744 (+0.32%) |
Filing History |
| 2024-01-31 4:30 pm Purchase |
2024-01-29 | 13D | Apogee Therapeutics, Inc. APGE |
Fairmount Funds Management LLC | 5,403,053 9.990% |
1,496,851 (+38.32%) |
Filing History |
| 2024-01-24 5:26 pm Purchase |
2024-01-22 | 13D | Dianthus Therapeutics, Inc. DNTH |
Fairmount Funds Management LLC | 2,960,747 9.900% |
1,086,914 (+58.00%) |
Filing History |
| 2024-01-24 5:12 pm Purchase |
2024-01-22 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 13,956,685 19.430% |
1,192,292 (+9.34%) |
Filing History |
| 2023-12-29 5:00 pm Sale |
2023-12-29 | 13D | Spyre Therapeutics, Inc. SYRE |
Fairmount Funds Management LLC | 836,459 2.320% |
-2,977,442 (-78.07%) |
Filing History |
| 2023-12-11 5:21 pm Unchanged |
2023-12-07 | 13D | Spyre Therapeutics, Inc. SYRE |
Fairmount Funds Management LLC | 3,813,901 10.590% |
0 (Unchanged) |
Filing History |
| 2023-11-29 5:08 pm Purchase |
2023-11-24 | 13D | Spyre Therapeutics, Inc. SYRE |
Fairmount Funds Management LLC | 3,813,901 12.700% |
3,813,901 (New Position) |
Filing History |
| 2023-11-03 4:30 pm Purchase |
2023-10-30 | 13D | Viridian Therapeutics, Inc. VRDN |
Fairmount Funds Management LLC | 12,764,393 19.990% |
3,571,579 (+38.85%) |
Filing History |
| 2023-10-10 4:30 pm Purchase |
2023-09-28 | 13G | Soleno Therapeutics, Inc. SLNO |
Fairmount Funds Management LLC | 950,000 6.200% |
950,000 (New Position) |
Filing History |